These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7939771

  • 21. [Lymphocyte T population in hemophilia A and its relation with factor VIII therapy and the presence of HBsAg or anti-F.VIII:C inhibitors].
    Aznar JA, Carbonell F, Jorquera JI, Carmona E, Sánchez-Cuenca JM, Trénor A, de Andrés-Medina R, González-Molina A.
    Sangre (Barc); 1985; 30(5):821-30. PubMed ID: 3937253
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Postpartum acquired factor VIII inhibitors.
    Franchini M.
    Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The use of rituximab in two children with allo-antibodies towards factor VIII.
    Curry N, Stanworth S, Keeling D.
    Br J Haematol; 2006 Apr; 133(2):214-6. PubMed ID: 16611318
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B, Mahendra A, Dimitrov JD, Friboulet A, Borel-Derlon A, Rao DN, Uda T, Borg JY, Bayry J, Kaveri SV, Lacroix-Desmazes S.
    FEBS Lett; 2009 Aug 06; 583(15):2565-72. PubMed ID: 19595998
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The treatment of factor VIII inhibitors--a general overview.
    White GC, Roberts HR.
    Vox Sang; 1996 Aug 06; 70 Suppl 1():19-23. PubMed ID: 8869464
    [Abstract] [Full Text] [Related]

  • 31. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R, Quintana Gonzalez S, Martinez Murillo C, Dominguez Garcia V, Rodriguez Moyado H, Collazo Jaloma J.
    Arch Med Res; 1996 Aug 06; 27(1):15-8. PubMed ID: 8867361
    [Abstract] [Full Text] [Related]

  • 32. Application of current knowledge to the management of bleeding events during immune tolerance induction.
    Di Paola J, Aledort L, Britton H, Carcao M, Grabowski E, Hutter J, Journeycake J, Kempton C, Leissinger C.
    Haemophilia; 2006 Nov 06; 12(6):591-7. PubMed ID: 17083508
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
    Hay CR, Lozier JN, Lee CA, Lafan M, Tradati H, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A.
    Semin Hematol; 1994 Apr 06; 31(2 Suppl 4):20-5. PubMed ID: 7939768
    [No Abstract] [Full Text] [Related]

  • 35. [Acquired factor VIII hemophilia in a geriatric patient].
    Boddi W, Machetti S, Sodi N, Sammicheli L, Cati G, Marotta G, Sabatini L, Cappelli R.
    Ann Ital Med Int; 2005 Apr 06; 20(3):192-6. PubMed ID: 16250186
    [Abstract] [Full Text] [Related]

  • 36. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M, Girelli D, Olivieri O, Bozzini C, Guiotto M, Zardini G, Lippi G, Manzato F, Gandin G.
    Haematologica; 2005 Mar 06; 90(3):ECR16. PubMed ID: 15753057
    [Abstract] [Full Text] [Related]

  • 37. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M.
    Rinsho Byori; 2001 Oct 06; 49(10):1000-4. PubMed ID: 11769464
    [Abstract] [Full Text] [Related]

  • 38. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A, Monzini M, Tagariello G, Scaraggi FA, Mannucci PM, Emoclot15 Study Members.
    Haemophilia; 2006 Mar 06; 12(2):128-32. PubMed ID: 16476086
    [Abstract] [Full Text] [Related]

  • 39. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I.
    Thromb Haemost; 1998 Apr 06; 79(4):872-5. PubMed ID: 9569207
    [Abstract] [Full Text] [Related]

  • 40. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS, Favaloro E, Koutts J.
    Am J Hematol; 2002 Aug 06; 70(4):330-1. PubMed ID: 12210817
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.